Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

77.02 -1.79 (-2.27%)

Streaming Delayed Price Updated: 2:01 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

August 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 19, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

August 19, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

An Overview of Alcon's Earnings ↗

August 18, 2025

Via Benzinga

Alcon Earnings Preview ↗

May 12, 2025

Via Benzinga

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical

August 19, 2025

From Alcon Inc. Investors

Via Business Wire

Tech Stocks Drop, Palantir Plunges Over 8%: What's Moving Markets Tuesday? ↗

August 19, 2025

Tech stocks pulled back on Tuesday as the absence of fresh bullish catalysts prompted investors to take profits after the recent months-long rally.

Via Benzinga

Earnings Scheduled For August 19, 2025 ↗

August 19, 2025

Via Benzinga

Predicting the Next Rule Breaker Buyout ↗

August 19, 2025

Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?

Via The Motley Fool

Topics Artificial Intelligence

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 18, 2025

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

August 12, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)

August 05, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition ↗

August 05, 2025

Alcon will acquire STAAR Surgical for $1.5 billion to expand surgical vision correction options for high myopia, including EVO ICL lenses.

Via Benzinga

Alcon Agrees to Acquire STAAR Surgical

August 05, 2025

From Alcon Inc. Investors

Via Business Wire

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

July 22, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

July 07, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 ↗

May 29, 2025

FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production.

Via Benzinga

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

May 28, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

May 14, 2025

Via Benzinga

American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday ↗

May 14, 2025

Via Benzinga

Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

May 13, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces Results of 2025 Annual General Meeting

May 06, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS

April 25, 2025

From Alcon Inc. Investors

Via Business Wire

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield

April 16, 2025

Via MarketBeat

Alcon Publishes Agenda for 2025 Annual General Meeting

April 04, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

April 02, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

March 26, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

March 25, 2025

From Alcon Inc. Investors

Via Business Wire

Alcon Eyes Surgical Edge With LENSAR Buyout: Details ↗

March 24, 2025

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser technologies, boosting Alcon's offerings in femtosecond laser-assisted cataract...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.